Status:

RECRUITING

Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

Lead Sponsor:

University Hospitals Cleveland Medical Center

Conditions:

Lung Nodule

Eligibility:

All Genders

18-89 years

Brief Summary

chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI...

Detailed Description

The study is a prospective study for measuring the performance of an AI software in detecting lung nodules from chest X-rays. Data collected during the study will be analyzed for study purposes after ...

Eligibility Criteria

Inclusion

  • Chest X-ray images of patients aged 18 - 89 years.
  • Modality: CR/DR/DX.
  • PA/view
  • Lung nodules measuring 6 mm -30 mm (for chest X-ray images where presence of nodules is required).

Exclusion

  • Incomplete view of the chest.
  • Lateral view
  • Known lung cancer at the time of Chest x-ray images.

Key Trial Info

Start Date :

June 24 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

45991 Patients enrolled

Trial Details

Trial ID

NCT06597968

Start Date

June 24 2025

End Date

December 1 2025

Last Update

July 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals

Cleveland, Ohio, United States, 44106

Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool | DecenTrialz